Ischemic neuronal damage

Current Pharmaceutical Design

Volumn 14, Issue 33, 2008, Pages 3565-3573

  Taoufik, Era ^a   Probert, Lesley ^a  

^a HELLENIC PASTEUR INSTITUTE   (Greece)

Author keywords

Apoptosis; Calcium; Cerebral ischemia; Excitotoxicity; Inflammation; Neuronal death; Neuroprotection; Stroke

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CASPASE INHIBITOR; DEATH RECEPTOR; ERYTHROPOIETIN; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 1BETA; MICRORNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; TUMOR NECROSIS FACTOR RECEPTOR; VASCULOTROPIN;

APOPTOSIS; BIOMECHANICS; BRAIN ISCHEMIA; CALCIUM CELL LEVEL; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CYTOKINE PRODUCTION; DEPOLARIZATION; EXCITOTOXICITY; HUMAN; HYPOXIA; NERVE CELL NECROSIS; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; TRAUMATIC BRAIN INJURY; CELL DEATH; NERVE CELL; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

BRAIN ISCHEMIA; CELL DEATH; HUMANS; NEURONS;

EID: 59849120171     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161208786848748     Document Type: Review

References (124)

1. Katsura K, Kristian T, Siesjo BK. Energy metabolism, ion homeostasis, and cell damage in the brain. Biochem Soc Trans 1994; 22(4): 991-6.
2. Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 1999; 22(9): 391-7.
3. Taylor TN, Davis PH, Torner JC, Holmes J, Meyer JW, Jacobson MF. Lifetime cost of stroke in the United States. Stroke 1996; 27(9): 1459-66.
4. Baron JC. Mapping the ischaemic penumbra with PET: A new approach. Brain 2001; 124(Pt 1): 2-4.
5. Lo EH, Moskowitz MA, Jacobs TP. Exciting, radical, suicidal: How brain cells die after stroke. Stroke 2005; 36(2): 189-92.
6. Tissue plasminogen activator for acute ischemic stroke. The national institute of neurological disorders and stroke rt-PA stroke study group. N Engl J Med 1995; 333(24): 1581-7.
7. Lo EH, Dalkara T, Moskowitz MA. Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci 2003; 4(5): 399-415.
8. Dirnagl U. Bench to bedside: The quest for quality in experimental stroke research. J Cereb Blood Flow Metab 2006; 26(12): 1465-78.
9. AMES A, III, GURIAN BS. Effects of glucose and oxygen deprivation on function of isolated mammalian retina. J Neurophysiol 1963; 26: 617-34.
10. Przybylski A, Krasnicka Z. Carbon monoxide effect on the membrane potential of cells in nervous tissue cultures. Acta Physiol Pol 1980; 31(2): 141-6.
11. Pulsinelli WA, Buchan AM. The four-vessel occlusion rat model: Method for complete occlusion of vertebral arteries and control of collateral circulation. Stroke 1988; 19(7): 913-4.
12. Smith ML, Bendek G, Dahlgren N, Rosen I, Wieloch T, Siesjo BK. Models for studying long-term recovery following forebrain ischemia in the rat. 2. A 2-vessel occlusion model. Acta Neurol Scand 1984; 69(6): 385-401.
13. Crumrine RC, LaManna JC, Lust WD. Regional changes in intracellular pH determined by neutral red histophotometry and high energy metabolites during cardiac arrest and following resuscitation in the rat. Metab Brain Dis 1991; 6(3): 145-55.
14. Kawai K, Nitecka L, Ruetzler CA, Nagashima G, Joo F, Mies G, et al. Global cerebral ischemia associated with cardiac arrest in the rat: I. Dynamics of early neuronal changes. J Cereb Blood Flow Metab 1992; 12(2): 238-49.
15. Pulsinelli WA, Brierley JB, Plum F. Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann Neurol 1982; 11(5): 491-8.
16. Kirino T, Tamura A, Sano K. Delayed neuronal death in the rat hippocampus following transient forebrain ischemia. Acta Neuropathol 1984; 64(2): 139-47.
17. Kirino T, Sano K. Selective vulnerability in the gerbil hippocampus following transient ischemia. Acta Neuropathol 1984; 62(3): 201-8.
18. Nitatori T, Sato N, Waguri S, Karasawa Y, Araki H, Shibanai K, Kominami E, Uchiyama Y. Delayed neuronal death in the CA1 pyramidal cell layer of the gerbil hippocampus following transient ischemia is apoptosis. J Neurosci 1995; 15(2): 1001-11.
19. Yamamoto K, Hayakawa T, Mogami H, Akai F, Yanagihara T. Ultrastructural investigation of the CA1 region of the hippocampus after transient cerebral ischemia in gerbils. Acta Neuropathol 1990; 80(5): 487-92.
20. Ginsberg MD, Busto R. Rodent models of cerebral ischemia. Stroke 1989; 20(12): 1627-42.
21. Tamura A, Graham DI, McCulloch J, Teasdale GM. Focal cerebral ischaemia in the rat: 1. Description of technique and early neuropathological consequences following middle cerebral artery occlusion. J Cereb Blood Flow Metab 1981; 1(1): 53-60.
22. Tamura A, Graham DI, McCulloch J, Teasdale GM. Focal cerebral ischaemia in the rat: 2. Regional cerebral blood flow determined by [14C]iodoantipyrine autoradiography following middle cerebral artery occlusion. J Cereb Blood Flow Metab 1981; 1(1): 61-9.
23. Bolander HG, Persson L, Hillered L, d'Argy R, Ponten U, Olsson Y. Regional cerebral blood flow and histopathologic changes after middle cerebral artery occlusion in rats. Stroke 1989; 20(7): 930-7.
24. Memezawa H, Minamisawa H, Smith ML, Siesjo BK. Ischemic penumbra in a model of reversible middle cerebral artery occlusion in the rat. Exp Brain Res 1992; 89(1): 67-78.
25. Buchan AM, Xue D, Slivka A. A new model of temporary focal neocortical ischemia in the rat. Stroke 1992; 23(2): 273-9.
26. Hossmann KA. Viability thresholds and the penumbra of focal ischemia. Ann Neurol 1994; 36(4): 557-65.
27. Lo EH. Experimental models, neurovascular mechanisms and translational issues in stroke research. Br J Pharmacol 2008; 153 Suppl 1: S396-405.
28. Astrup J, Nordstrom CH, Rehncrona S. Rate of rise in extracellular potassium in the ischemic rat brain and the effect of preischemic metabolic rate: Evidence for a specific effect of phenobarbitone. Acta Neurol Scand Suppl 1977; 64: 148-9.
29. Lee JM, Zipfel GJ, Choi DW. The changing landscape of ischaemic brain injury mechanisms. Nature 1999; 399(6738 Suppl): A7-14.
30. Iadecola C, Alexander M. Cerebral ischemia and inflammation. Curr Opin Neurol 2001; 14(1): 89-94.
31. Choi DW. Ischemia-induced neuronal apoptosis. Curr Opin Neurobiol 1996; 6(5): 667-72.
32. Baird AE, Benfield A, Schlaug G, Siewert B, Lovblad KO, Edelman RR, et al. Enlargement of human cerebral ischemic lesion volumes measured by diffusion-weighted magnetic resonance imaging. Ann Neurol 1997; 41(5): 581-9.
33. Rice JE, III, Vannucci RC, Brierley JB. The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann Neurol 1981; 9(2): 131-41.
34. Vannucci RC. Experimental biology of cerebral hypoxia-ischemia: Relation to perinatal brain damage. Pediatr Res 1990; 27(4 Pt 1): 317-26.
35. Cheng Y, Deshmukh M, D'Costa A, Demaro JA, Gidday JM, Shah A, et al. Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxic-ischemic brain injury. J Clin Invest 1998; 101(9): 1992-9.
36. Strasser U, Fischer G. Quantitative measurement of neuronal degeneration in organotypic hippocampal cultures after combined oxygen/glucose deprivation. J Neurosci Methods 1995; 57(2): 177-86.
37. Goldberg MP, Choi DW. Combined oxygen and glucose deprivation in cortical cell culture: Calcium-dependent and calcium-independent mechanisms of neuronal injury. J Neurosci 1993; 13(8): 3510-24.
38. Strasser U, Fischer G. Protection from neuronal damage induced by combined oxygen and glucose deprivation in organotypic hippocampal cultures by glutamate receptor antagonists. Brain Res 1995; 687(1-2): 167-74.
39. Taoufik E, Valable S, Muller GJ, Roberts ML, Divoux D, Tinel A, et al. FLIP(L) protects neurons against in vivo ischemia and in vitro glucose deprivation-induced cell death. J Neurosci 2007; 27(25): 6633-46.
40. Mattson MP, Culmsee C, Yu ZF. Apoptotic and antiapoptotic mechanisms in stroke. Cell Tissue Res 2000; 301(1): 173-87.
41. Nicotera P, Lipton SA. Excitotoxins in neuronal apoptosis and necrosis. J Cereb Blood Flow Metab 1999; 19(6): 583-91.
42. Onteniente B, Rasika S, Benchoua A, Guegan C. Molecular pathways in cerebral ischemia: Cues to novel therapeutic strategies. Mol Neurobiol 2003; 27(1): 33-72.
43. Brown AW. Structural abnormalities in neurones. J Clin Pathol Suppl (R Coll Pathol) 1977; 11: 155-69.
44. Lukaszevicz AC, Sampaio N, Guegan C, Benchoua A, Couriaud C, Chevalier E, et al. High sensitivity of protoplasmic cortical astroglia to focal ischemia. J Cereb Blood Flow Metab 2002; 22(3): 289-98.
45. Kerr JF, Wyllie AH, Currie AR. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26(4): 239-57.
46. Arends MJ, Wyllie AH. Apoptosis: Mechanisms and roles in pathology. Int Rev Exp Pathol 1991; 32: 223-54.
47. Hengartner MO. The biochemistry of apoptosis. Nature 2000; 407(6805): 770-6.
48. Velier JJ, Ellison JA, Kikly KK, Spera PA, Barone FC, Feuerstein GZ. Caspase-8 and caspase-3 are expressed by different populations of cortical neurons undergoing delayed cell death after focal stroke in the rat. J Neurosci 1999; 19(14): 5932-41.
49. Guglielmo MA, Chan PT, Cortez S, Stopa EG, McMillan P, Johanson CE, et al. The temporal profile and morphologic features of neuronal death in human stroke resemble those observed in experimental forebrain ischemia: The potential role of apoptosis. Neurol Res 1998; 20(4): 283-96.
50. Love S, Barber R, Wilcock GK. Apoptosis and expression of DNA repair proteins in ischaemic brain injury in man. Neuroreport 1998; 9(6): 955-9.
51. Borsello T, Croquelois K, Hornung JP, Clarke PG. N-methyl-daspartate- triggered neuronal death in organotypic hippocampal cultures is endocytic, autophagic and mediated by the c-Jun Nterminal kinase pathway. Eur J Neurosci 2003; 18(3): 473-85.
52. LUCAS DR, NEWHOUSE JP. The toxic effect of sodium Lglutamate on the inner layers of the retina. AMA Arch Ophthalmol 1957; 58(2): 193-201.
53. Olney JW. Glutamate-induced neuronal necrosis in the infant mouse hypothalamus. An electron microscopic study. J Neuropathol Exp Neurol 1971; 30(1): 75-90.
54. Abramov AY, Scorziello A, Duchen MR. Three distinct mechanisms generate oxygen free radicals in neurons and contribute to cell death during anoxia and reoxygenation. J Neurosci 2007; 27(5): 1129-38.
55. Silver IA, Deas J, Erecinska M. Ion homeostasis in brain cells: differences in intracellular ion responses to energy limitation between cultured neurons and glial cells. Neuroscience 1997; 78(2): 589-601.
56. Hansen AJ, Nedergaard M. Brain ion homeostasis in cerebral ischemia. Neurochem Pathol 1988; 9: 195-209.
57. Phillis JW, Smith-Barbour M, O'Regan MH. Changes in extracellular amino acid neurotransmitters and purines during and following ischemias of different durations in the rat cerebral cortex. Neurochem Int 1996; 29(2): 115-20.
58. Choi DW. Calcium: Still center-stage in hypoxic-ischemic neuronal death. Trends Neurosci 1995; 18(2): 58-60.
59. Orrenius S, Zhivotovsky B, Nicotera P. Regulation of cell death: The calcium-apoptosis link. Nat Rev Mol Cell Biol 2003; 4(7): 552-65.
60. Kermer P, Klocker N, Bahr M. Neuronal death after brain injury. Models, mechanisms, and therapeutic strategies in vivo. Cell Tissue Res 1999; 298(3): 383-95.
61. Hayashi T, Sakurai M, Itoyama Y, Abe K. Oxidative damage and breakage of DNA in rat brain after transient MCA occlusion. Brain Res 1999; 832(1-2): 159-63.
62. Braughler JM, Hall ED. Central nervous system trauma and stroke. I. Biochemical considerations for oxygen radical formation and lipid peroxidation. Free Radic Biol Med 1989; 6(3): 289-301.
63. Yu ZF, Bruce-Keller AJ, Goodman Y, Mattson MP. Uric acid protects neurons against excitotoxic and metabolic insults in cell culture, and against focal ischemic brain injury in vivo. J Neurosci Res 1998; 53(5): 613-25.
64. Tagami M, Ikeda K, Yamagata K, Nara Y, Fujino H, Kubota A, et al. Vitamin E prevents apoptosis in hippocampal neurons caused by cerebral ischemia and reperfusion in stroke-prone spontaneously hypertensive rats. Lab Invest 1999; 79(5): 609-15.
65. Weisbrot-Lefkowitz M, Reuhl K, Perry B, Chan PH, Inouye M, Mirochnitchenko O. Overexpression of human glutathione peroxidase protects transgenic mice against focal cerebral ischemia/reperfusion damage. Brain Res Mol Brain Res 1998; 53(1-2): 333-8.
66. Kondo T, Reaume AG, Huang TT, Murakami K, Carlson E, Chen S, et al. Edema formation exacerbates neurological and histological outcomes after focal cerebral ischemia in CuZn-superoxide dismutase gene knockout mutant mice. Acta Neurochir Suppl 1997; 70: 62-4.
67. Murakami K, Kondo T, Kawase M, Li Y, Sato S, Chen SF, et al. Mitochondrial susceptibility to oxidative stress exacerbates cerebral infarction that follows permanent focal cerebral ischemia in mutant mice with manganese superoxide dismutase deficiency. J Neurosci 1998; 18(1): 205-13.
68. Keller JN, Mark RJ, Bruce AJ, Blanc E, Rothstein JD, Uchida K, et al. 4-Hydroxynonenal, an aldehydic product of membrane lipid peroxidation, impairs glutamate transport and mitochondrial function in synaptosomes. Neuroscience 1997; 80(3): 685-96.
69. Mark RJ, Keller JN, Kruman I, Mattson MP. Basic FGF attenuates amyloid beta-peptide-induced oxidative stress, mitochondrial dysfunction, and impairment of Na+/K+-ATPase activity in hippocampal neurons. Brain Res 1997; 756(1-2): 205-14.
70. Dugan LL, Choi DW. Excitotoxicity, free radicals, and cell membrane changes. Ann Neurol 1994; 35 Suppl: S17-21.
71. Ankarcrona M, Dypbukt JM, Bonfoco E, Zhivotovsky B, Orrenius S, Lipton SA, et al. Glutamate-induced neuronal death: A succession of necrosis or apoptosis depending on mitochondrial function. Neuron 1995; 15(4): 961-73.
72. Chen J, Graham SH, Simon RP. A comparison of the effects of a sodium channel blocker and an NMDA antagonist upon extracellular glutamate in rat focal cerebral ischemia. Brain Res 1995; 699(1): 121-4.
73. Hu BR, Kurihara J, Wieloch T. Persistent translocation and inhibition of Ca2+/calmodulin-dependent protein kinase II in the crude synaptosomal fraction of the vulnerable hippocampus following hypoglycemia. J Neurochem 1995; 64(3): 1361-9.
74. Young D, Lawlor PA, Leone P, Dragunow M, During MJ. Environmental enrichment inhibits spontaneous apoptosis, prevents seizures and is neuroprotective. Nat Med 1999; 5(4): 448-53.
75. Ikonomidou C, Stefovska V, Turski L. Neuronal death enhanced by N-methyl-D-aspartate antagonists. Proc Natl Acad Sci USA 2000; 97(23): 12885-90.
76. Linnik MD, Zobrist RH, Hatfield MD. Evidence supporting a role for programmed cell death in focal cerebral ischemia in rats. Stroke 1993; 24(12): 2002-8.
77. Martinou JC, Dubois-Dauphin M, Staple JK, Rodriguez I, Frankowski H, Missotten M, et al. Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron 1994; 13(4): 1017-30.
78. Pettmann B, Henderson CE. Neuronal cell death. Neuron 1998; 20(4): 633-47.
79. Kitagawa K, Matsumoto M, Tsujimoto Y, Ohtsuki T, Kuwabara K, Matsushita K, et al. Amelioration of hippocampal neuronal damage after global ischemia by neuronal overexpression of BCL-2 in transgenic mice. Stroke 1998; 29(12): 2616-21.
80. Cao G, Pei W, Ge H, Liang Q, Luo Y, Sharp FR, et al. In Vivo Delivery of a Bcl-xL Fusion Protein Containing the TAT Protein Transduction Domain Protects against Ischemic Brain Injury and Neuronal Apoptosis. J Neurosci 2002; 22(13): 5423-31.
81. Kilic E, Dietz GP, Hermann DM, Bahr M. Intravenous TAT-Bcl-Xl is protective after middle cerebral artery occlusion in mice. Ann Neurol 2002; 52(5): 617-22.
82. Deng Y, Ren X, Yang L, Lin Y, Wu X. A JNK-dependent pathway is required for TNFalpha-induced apoptosis. Cell 2003; 115(1): 61-70.
83. Martin-Villalba A, Herr I, Jeremias I, Hahne M, Brandt R, Vogel J, et al. CD95 ligand (Fas-L/APO-1L) and tumor necrosis factorrelated apoptosis-inducing ligand mediate ischemia-induced apoptosis in neurons. J Neurosci 1999; 19(10): 3809-17.
84. Demjen D, Klussmann S, Kleber S, Zuliani C, Stieltjes B, Metzger C, et al. Neutralization of CD95 ligand promotes regeneration and functional recovery after spinal cord injury. Nat Med 2004.
85. Dorr J, Bechmann I, Waiczies S, Aktas O, Walczak H, Krammer PH, et al. Lack of tumor necrosis factor-related apoptosis-inducing ligand. J Neurosci 2002; 22(4): RC209.
86. Benchoua A, Couriaud C, Guegan C, Tartier L, Couvert P, Friocourt G, et al. Active caspase-8 translocates into the nucleus of apoptotic cells to inactivate poly(ADP-ribose) polymerase-2. J Biol Chem 2002; 277(37): 34217-22.
87. Feng Y, Fratkin JD, LeBlanc MH. Inhibiting caspase-8 after injury reduces hypoxic-ischemic brain injury in the newborn rat. Eur J Pharmacol 2003; 481(2-3): 169-73.
88. Tschopp J, Irmler M, Thome M. Inhibition of fas death signals by FLIPs. Curr Opin Immunol 1998; 10(5): 552-8.
89. Hara H, Friedlander RM, Gagliardini V, Ayata C, Fink K, Huang Z, et al. Inhibition of interleukin 1beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. Proc Natl Acad Sci USA 1997; 94(5): 2007-12.
90. Endres M, Namura S, Shimizu-Sasamata M, Waeber C, Zhang L, Gomez-Isla T, et al. Attenuation of delayed neuronal death after mild focal ischemia in mice by inhibition of the caspase family. J Cereb Blood Flow Metab 1998; 18(3): 238-47.
91. Brecht S, Gelderblom M, Srinivasan A, Mielke K, Dityateva G, Herdegen T. Caspase-3 activation and DNA fragmentation in primary hippocampal neurons following glutamate excitotoxicity. Brain Res Mol Brain Res 2001; 94(1-2): 25-34.
92. Le DA, Wu Y, Huang Z, Matsushita K, Plesnila N, Augustinack JC, et al. Caspase activation and neuroprotection in caspase-3-deficient mice after in vivo cerebral ischemia and in vitro oxygen glucose deprivation. Proc Natl Acad Sci USA 2002; 99(23): 15188-93.
93. Xu DG, Crocker SJ, Doucet JP, St Jean M, Tamai K, Hakim AM, et al. Elevation of neuronal expression of NAIP reduces ischemic damage in the rat hippocampus. Nat Med 1997; 3(9): 997-1004.
94. Guegan C, Braudeau J, Couriaud C, Dietz GP, Lacombe P, Bahr M, et al. PTD-XIAP protects against cerebral ischemia by antiapoptotic and transcriptional regulatory mechanisms. Neurobiol Dis 2006; 22(1): 177-86.
95. Schulz JB, Nicotera P. Introduction: Targeted modulation of neuronal apoptosis: A. Brain Pathol 2000; 10(2): 273-5.
96. Mattson MP. Apoptotic and anti-apoptotic synaptic signaling mechanisms. Brain Pathol 2000; 10(2): 300-12.
97. Botchkina GI, Meistrell ME, III, Botchkina IL, Tracey KJ. Expression of TNF and TNF receptors (p55 and p75) in the rat brain after focal cerebral ischemia. Mol Med 1997; 3(11): 765-81.
98. Hallenbeck JM. The many faces of tumor necrosis factor in stroke. Nat Med 2002; 8(12): 1363-8.
99. Barone FC, Arvin B, White RF, Miller A, Webb CL, Willette RN, et al. Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury. Stroke 1997; 28(6): 1233-44.
100. Dawson DA, Martin D, Hallenbeck JM. Inhibition of tumor necrosis factor-alpha reduces focal cerebral. Neurosci Lett 1996; 218(1): 41-44.
101. Martin-Villalba A, Hahne M, Kleber S, Vogel J, Falk W, Schenkel J, et al. Therapeutic neutralization of CD95-ligand and TNF attenuates brain damage in stroke. Cell Death Differ 2001; 8(7): 679-86.
102. Furukawa K, Mattson MP. The transcription factor NF-kappaB mediates increases in calcium currents and decreases in. J Neurochem 1998; 70(5): 1876-86.
103. Bruce AJ, Boling W, Kindy MS, Peschon J, Kraemer PJ, Carpenter MK, et al. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nat Med 1996; 2(7): 788-94.
104. Nawashiro H, Tasaki K, Ruetzler CA, Hallenbeck JM. TNF-alpha pretreatment induces protective effects against focal cerebral ischemia in mice. J Cereb Blood Flow Metab 1997; 17(5): 483-90.
105. Scherbel U, Raghupathi R, Nakamura M, Saatman KE, Trojanowski JQ, Neugebauer E, et al. Differential acute and chronic responses of tumor necrosis factor-deficient mice to experimental brain injury. Proc Natl Acad Sci USA 1999; 96(15): 8721-6.
106. Mattson MP, Camandola S. NF-kappaB in neuronal plasticity and neurodegenerative disorders. J Clin Invest 2001; 107(3): 247-54.
107. Meffert MK, Chang JM, Wiltgen BJ, Fanselow MS, Baltimore D. NF-kappa B functions in synaptic signaling and behavior. Nat Neurosci 2003; 6(10): 1072-8.
108. Bhakar AL, Howell JL, Paul CE, Salehi AH, Becker EB, Said F, et al. Apoptosis induced by p75NTR overexpression requires Jun kinase-dependent phosphorylation of Bad. J Neurosci 2003; 23(36): 11373-81.
109. Fridmacher V, Kaltschmidt B, Goudeau B, Ndiaye D, Rossi FM, Pfeiffer J, 113. Forebrain-specific neuronal inhibition of nuclear factor-kappaB activity leads to loss of neuroprotection. J Neurosci 2003; 23(28): 9403-8.
110. Herdegen T, Waetzig V. AP-1 proteins in the adult brain: Facts and fiction about effectors of neuroprotection and neurodegeneration. Oncogene 2001; 20(19): 2424-37.
111. Buttini M, Sauter A, Boddeke HW. Induction of interleukin-1 beta mRNA after focal cerebral ischaemia in the rat. Brain Res Mol Brain Res 1994; 23(1-2): 126-34.
112. Griffin WS, Sheng JG, Gentleman SM, Graham DI, Mrak RE, Roberts GW. Microglial interleukin-1 alpha expression in human head injury: correlations with neuronal and neuritic beta-amyloid precursor protein expression. Neurosci Lett 1994; 176(2): 133-6.
113. Loddick SA, Rothwell NJ. Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal cerebral ischaemia in the rat. J Cereb Blood Flow Metab 1996; 16(5): 932-40.
114. Lawrence CB, Allan SM, Rothwell NJ. Interleukin-1beta and the interleukin-1 receptor antagonist act in the striatum to modify excitotoxic brain damage in the rat. Eur J Neurosci 1998; 10(3): 1188-95.
115. Serou MJ, DeCoster MA, Bazan NG. Interleukin-1 beta activates expression of cyclooxygenase-2 and inducible nitric oxide synthase in primary hippocampal neuronal culture: Platelet-activating factor as a preferential mediator of cyclooxygenase-2 expression. J Neurosci Res 1999; 58(4): 593-8.
116. Brines ML, Ghezzi P, Keenan S, Agnello D, de Lanerolle NC, Cerami C, et al. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Natl Acad Sci USA 2000; 97(19): 10526-31.
117. Bernaudin M, Marti HH, Roussel S, Divoux D, Nouvelot A, MacKenzie ET, et al. potential role for erythropoietin in focal permanent cerebral ischemia in mice. J Cereb Blood Flow Metab 1999; 19(6): 643-51.
118. Sakanaka M, Wen TC, Matsuda S, Masuda S, Morishita E, Nagao M, et al. In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc Natl Acad Sci USA 1998; 95(8): 4635-40.
119. Ehrenreich H, Hasselblatt M, Dembowski C, Cepek L, Lewczuk P, Stiefel M, et al. Erythropoietin therapy for acute stroke is both safe and beneficial. Mol Med 2002; 8(8): 495-505.
120. Sun Y, Jin K, Xie L, Childs J, Mao XO, Logvinova A, Greenberg DA. VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J Clin Invest 2003; 111(12): 1843-51.
121. Borlongan CV, Hess DC. New hope for stroke patients: Mobilization of endogenous stem cells. CMAJ 2006; 174(7): 954-5.
122. Taoufik E, Petit E, Divoux D, Tseveleki V, Mengozzi M, Roberts ML, et al. TNF receptor I sensitizes neurons to erythropoietin- and VEGF-mediated neuroprotection after ischemic and excitotoxic injury. Proc Natl Acad Sci USA 2008; 105(16): 6185-90.
123. Bernaudin M, Tang Y, Reilly M, Petit E, Sharp FR. Brain genomic response following hypoxia and re-oxygenation in the neonatal rat. Identification of genes that might contribute to hypoxia-induced ischemic tolerance. J Biol Chem 2002; 277(42): 39728-38.
124. Jeyaseelan K, Lim KY, Armugam A. MicroRNA expression in the blood and brain of rats subjected to transient focal ischemia by middle cerebral artery occlusion. Stroke 2008; 39(3): 959-66.